Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades

Past published studies have already documented that, subsequent to the intravenous injection of colloidal lipid nanocarriers, apolipoprotein (apo)A-I is adsorbed from the blood onto the nanoparticle surface. The adsorbed apoA-I mediates the interaction of the nanoparticle with scavenger receptors on...

Descripción completa

Detalles Bibliográficos
Autor principal: D’Arrigo, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148491/
https://www.ncbi.nlm.nih.gov/pubmed/32244941
http://dx.doi.org/10.3390/biomimetics5010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148491/
https://www.ncbi.nlm.nih.gov/pubmed/32244941
http://dx.doi.org/10.3390/biomimetics5010011

Ejemplares similares